Literature DB >> 29150222

Retrospective study of thoracotomy performed in a French level 1-trauma center.

A Mancini1, A Bonne1, A Pirvu2, P Porcu3, P Bouzat4, J Abba1, C Arvieux5.   

Abstract

OBJECTIVE: Resuscitative thoracotomy, a potentially life-saving procedure, is used exceptionally, and essentially for penetrating trauma. Most of the available literature is American while reports from Europe are sparse. We report our experience in a French level 1-trauma center.
MATERIAL AND METHODS: Patient records (patient age, gender, mechanism of injury, indication for emergency thoracotomy, anatomic injuries, interventions and survival) for all patients who underwent emergency thoracotomy between January 2005 and December 2015 were analyzed.
RESULTS: Twenty-two patients (19 males) underwent emergency thoracotomy. Median age was 27.5 (12-67) years. Twelve were performed for blunt trauma (55%) and 10 for penetrating injuries (45%). Thirteen patients presented with cardiac arrest, while nine had deep and refractory hypotension. Overall, survival was 32% (n=7). There were no survivors in the blunt trauma group while seven of ten with penetrating injuries survived. All patients presenting with cardiac arrest died.
CONCLUSION: The survival rate in this French retrospective study was in accordance with the literature.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Blunt trauma; Cardiac arrest; Emergency thoracotomy; Penetrating trauma; Resuscitative thoracotomy

Mesh:

Year:  2017        PMID: 29150222     DOI: 10.1016/j.jviscsurg.2017.05.007

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  1 in total

1.  Emergency department thoracotomy in a physician-staffed trauma system: the experience of a French Military level-1 trauma center.

Authors:  Hilaire de Malleray; Michael Cardinale; Jean-Philippe Avaro; Eric Meaudre; Tristan Monchal; Stéphane Bourgouin; Mathieu Vasse; Paul Balandraud; Henri de Lesquen
Journal:  Eur J Trauma Emerg Surg       Date:  2022-05-28       Impact factor: 3.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.